Table 1 General data of the two groups.
 | GDM group | Control group | t/z/χ2 | P value | ||
---|---|---|---|---|---|---|
\(\overline{X}\)/\(M\) | \(S\)/\(IQR\) | \(\overline{X}\)/\(M\) | \(S\)/\(IQR\) | |||
Male/female | 21/16 | 23/11 | 0.89 | 0.35 | ||
Gestational age (weeks) | 35.57 | 34.43–37.93 | 35.50 | 34.54–38.21 | − 0.09 | 0.93 |
Days since birth | 7 | 5–9.50 | 7 | 5–9 | − 0.10 | 0.92 |
Body length (cm) | 45.95 | 2.90 | 45.41 | 3.36 | 0.72 | 0.48 |
Weight (g) | 2450 | 2120–2880 | 2450 | 2010–2772.5 | − 0.76 | 0.45 |
Head girth (cm) | 32.09 | 1.35 | 32.09 | 1.90 | 0.07 | 0.99 |
Neonatal blood glucose value (mmol/l) | 2.90 | 2–4 | 2.85 | 2.4–4.03 | − 0.52 | 0.60 |
Blood PH | 7.30 | 0.07 | 7.33 | 0.07 | 0.73 | 0.22 |
Apgar score (1 min) | 9 | 8–10 | 10 | 7.75–10 | − 0.64 | 0.53 |
Apgar score (5 min) | 10 | 9–10 | 10 | 9–10 | − 0.22 | 0.83 |
Apgar score (10 min) | 10 | 10 | 10 | 10 | − 0.05 | 0.96 |